Stan Majewski, PhD

Profile-for-Web

Stan Majewski, PhD

Assistant Professor of Radiology and Medical Imaging

MS, Physics, University of Warsaw, 1971
PhD, High Energy Physics, University of Warsaw, 1979

University of Virginia
Department of Radiology and Medical Imaging
Fontaine Research Park
480 Ray C. Hunt Dr.
Charlottesville, VA 22903

SM4AA@hscmail.mcc.virginia.edu
757-206-3962

Research Interests

Dr. Majewski is not a typical biomedical imaging researcher. His primary area of focus has been in the area of radiation detection, and over the past 40 years he has been involved in the development of various new detectors and detection techniques—first for high energy elementary particles then for beta and gamma radiation. Dr. Majewski’s early career was dedicated to the advancement of radiation detection techniques as well as the development of detectors for experimental particle physics. However, his interests have always been multidisciplinary.

Throughout his career, Dr. Majewski has also worked on developing biomedical imaging techniques and related instruments, such as proton radiography and X-ray imaging. In 2009 he devoted himself entirely to developing medical imaging instrumentation when, after working for almost 20 years in the national nuclear physics laboratory (Jefferson Lab), he moved to academia.

Dr. Majewski has extensive experience in developing dedicated nuclear medicine (single gamma and PET) imaging instrumentation for imaging of the breast, brain, heart and the prostate, and for small animals, both conceptually and working prototypes. In the area of instrumentation research, his primary focus has been the practical application of these concepts, which will ultimately lead to useful pre-clinical and clinical applications.

Research Lab

Development of Organ-Specific Dedicated Nuclear Medicine Imagers

In the News

Previous Research

  • Development of dedicated nuclear medicine breast imagers (gamma and PET)
  • Development of dedicated upright brain imagers
  • Development of mobile imagers for surgery and radiosurgery applications
  • Development of a dedicated prostate PET
  • Development and application of small animal imagers (single gamma and PET)

Publications

Designing a compact high performance brain PET scanner-simulation study.
Gong K, Majewski S, Kinahan PE, Harrison RL, Elston BF, Manjeshwar R, Dolinsky S, Stolin AV, Brefczynski-Lewis JA, Qi J.
Phys Med Biol. 2016 May 21;61(10):3681-97. doi: 10.1088/0031-9155/61/10/3681. Epub 2016 Apr 15.

A novel method for γ photons depth of interaction discrimination on monolithic LYSO crystals for brain PET/MRI.
Pani R, Bettiol M, Preziosi E, Borrazzo C, Pellegrini R, Gonzalez A, Conde P, Cinti MN, Fabbri A, Di Castro E, Majewski S.
EJNMMI Phys. 2015 Dec;2(Suppl 1):A11. doi: 10.1186/2197-7364-2-S1-A11. No abstract available.

Progress report on the MindView brain PET detector module based on large area SiPMs arrays.
González AJ, Majewski S, Conde P, Hernández L, Sánchez F, Bellido P, Crespo E, Iborra A, Moliner L, Rigla JP, Rodríguez-Álvarez MJ, Seimetz M, Soriano A, Stolin A, Vidal LF, Benlloch JM.
EJNMMI Phys. 2014 Jul;1(Suppl 1):A66. doi: 10.1186/2197-7364-1-S1-A66. No abstract available.

Combined (1)H MRI, PET and Multinuclear MRS hybrid imaging system.
Hankiewicz JH, Celinski Z, Smiley K, Majewski S.
EJNMMI Phys. 2014 Jul;1(Suppl 1):A6. doi: 10.1186/2197-7364-1-S1-A6. No abstract available.

Bispecific antibody complex pre-targeting and targeted delivery of polymer drug conjugates for imaging and therapy in dual human mammary cancer xenografts: targeted polymer drug conjugates for cancer diagnosis and therapy.
Khaw BA, Gada KS, Patil V, Panwar R, Mandapati S, Hatefi A, Majewski S, Weisenberger A.
Eur J Nucl Med Mol Imaging. 2014 Aug;41(8):1603-16. doi: 10.1007/s00259-014-2738-2. Epub 2014 Mar 19.

Construction and Evaluation of a Prototype High Resolution, Silicon Photomultiplier-Based, Tandem Positron Emission Tomography System.
Stolin AV, Majewski S, Jaliparthi G, Raylman RR.
IEEE Trans Nucl Sci. 2013 Feb;60(1):82-86.

In vitro demonstration of enhanced prostate cancer toxicity: pretargeting with Bombesin bispecific complexes and targeting with polymer-drug-conjugates.
Patil V, Gada K, Panwar R, Majewski S, Tekabe Y, Varvarigou A, Khaw BA.
J Drug Target. 2013 Dec;21(10):1012-21. doi: 10.3109/1061186X.2013.818675. Epub 2013 Jul 18.

More Publications (PubMed)